Core Insights - The 2025 China International Service Trade Fair featured the third Traditional Chinese Medicine (TCM) Conference organized by Beijing Tongrentang, focusing on "Intelligent TCM Leading Health, Innovative Services for the Future" [1] - The conference aimed to accelerate the integration of TCM with digital intelligence and to create a new blueprint for high-quality development in the TCM sector, contributing to global health governance [1][8] Group 1: Conference Highlights - The conference gathered over 1,300 TCM professionals and more than 50,000 online participants, showcasing the importance of TCM in health services [1] - Keynote speeches from prominent experts emphasized the need for TCM modernization while maintaining its core principles, discussing the opportunities and challenges presented by artificial intelligence [5][6] - A new key laboratory focusing on TCM theories for epidemic prevention and treatment was launched, aiming to enhance research and innovation in TCM [6] Group 2: Strategic Directions - The leadership from the National Administration of Traditional Chinese Medicine and other officials praised Beijing Tongrentang for its role in TCM innovation and its "three-in-one" treatment system [3] - The conference emphasized the importance of collaboration and shared development in TCM, aiming to create a comprehensive service network that integrates wisdom and culture [3][4] - The event featured a structured agenda with multiple forums covering various TCM specialties, promoting academic exchange and practical experience sharing [7] Group 3: Future Outlook - The successful hosting of the conference is seen as a new starting point for the TCM industry, focusing on innovation through tradition and aiming for greater contributions to public health and international TCM development [8]

中国内地最大人工智能赋能的中医医疗服务提供商。 本文为IPO早知道原创 作者｜苏打 微信公众号｜ipozaozhidao 据IPO早知道消息，1月9日，问止中医科技正式向港交所递交招股说明书，拟主板挂牌上市。海通国 际为独家保荐人。 问止中医招股书显示，2022年公司全年营收6220万元（人民币，下同），2023年增加至1.89亿 元，同比增长204.0%。截至2024年9月30日，公司前9个月营收1.73亿元，2023年同期为1.294 亿元，同比增加33.8%。 截至2024年9 月30日，公司经调整净利（非香港财务报告准则计量）4950万元，较2023年同期的 2090万元增加137.4%。2023年度净溢利4300万元，较2022年5200万元增加735.2%。 据悉，问止中医专注于治疗癌重症以及疑难症，同时在全科医疗方面拥有坚实的基础，以专有的中医 大脑作为技术基础，致力于凭借人工智能，提高中医治疗的疗效，突破癌重症治疗瓶颈，解决疑难症 医疗问题及振兴中医。 其中， 中医大脑及精一书院 为公司 两大业务支柱， 主要解决中国内地中医医疗服务行业高度分 散、供需两端不平衡的痛点。根据灼识咨询报告，202 ...